Streetbeat News

Stock Prices

AYURF

Ayurcann Holdings Corp. reported a 127.7% YoY revenue growth for Q3, with net revenue of CA$6.49 million. The company also saw a significant improvement in gross revenue, net loss, and adjusted EBITDA. Shares closed 1.21% higher at $0.03 per share.

Portfolio Pulse from Nina Zdinjak

May 28, 2024 | 12:37 pm

SERA

Sera Prognostics Inc. (NASDAQ:SERA) is expected to be added to the Russell 2000 and 3000 indexes as part of the Russell indexes annual reconstitution. This inclusion could increase the stock's visibility and attract more investors.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:37 pm

BNIX

Bannix Acquisition Corp. has received a non-compliance notification from NASDAQ, indicating that the company is not meeting the exchange's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:37 pm

XENE

Xenon Pharmaceuticals presented Phase 2 X-NOVA clinical trial data of Azetukalner in Major Depressive Disorder at the ASCP 2024 Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:36 pm

JAGX

Jaguar Health announced that a study showed twice-daily administration of Crofelemer significantly reduces abdominal pain and improves stool consistency in patients with functional diarrhea compared to a placebo.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:34 pm

NIVF

NewGenIvf has received two letters from Nasdaq. The first letter is a notification of non-compliance with Nasdaq's minimum bid price requirement, as the company's stock has closed below $1.00 per share for 30 consecutive business days. The second letter is a notification of non-compliance with Nasdaq's minimum stockholders' equity requirement, as the company's stockholders' equity is below $2.5 million. NewGenIvf has 180 calendar days to regain compliance with the minimum bid price requirement and 45 calendar days to submit a plan to regain compliance with the minimum stockholders' equity requirement.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:34 pm

NBIX

Neurocrine Biosciences will present data from its neuroendocrinology pipeline at ENDO 2024, including new Phase 3 CAHtalyst data in adult and pediatric patients with congenital adrenal hyperplasia (CAH) and study data for modified-release hydrocortisone (MRHC) in primary adrenal insufficiency.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:34 pm

AAPL

INTC

NVDA

SOXQ

TSM

USD

Taiwan Semiconductor Manufacturing Co (TSMC) leverages Asia's skilled engineers and disciplined work culture for advanced semiconductor production. TSMC is addressing talent shortages by collaborating with universities to set up specialized graduate schools. The company plans to build new fabs in Taiwan and is considering a second plant in Japan. TSMC stock has gained 57% in the last 12 months.

Portfolio Pulse from Anusuya Lahiri

May 28, 2024 | 12:33 pm

SGHT

Sight Sciences has published the results of its ROMEO study in the Journal of Clinical Ophthalmology, highlighting significant findings in the field of ophthalmology.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:32 pm

AQST

Aquestive Therapeutics announced two encore poster presentations at the Eastern Allergy Conference, showcasing positive pharmacokinetic (PK) and pharmacodynamic (PD) data from clinical studies for Anaphylm™ (Epinephrine) Sublingual Film.

Portfolio Pulse from Benzinga Newsdesk

May 28, 2024 | 12:31 pm